Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
PaperCitations, authors & open-access status
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,972 citations, 2011 year and green oa status.
1,972
Citations
2011
Year
green
OA Status